About
Chris Halloran graduated from Liverpool University (Intercalated BSc in Microbiology 1992; MB ChB with commendation 1994). Following house jobs, he taught anatomy in Liverpool, attaining part 1 Fellow Royal College of Surgeons (FRCS). Chris then undertook basic surgical training across Merseyside receiving full FRCS (Eng) in 1998. Further research was undertaken (with Eithne Costello and John Neoptolemos) into the effects of combination chemo-gene therapy on pancreas cancer, resulting in award of an MD in 2005. Chris was appointed clinical lecturer in 2002, awarded FRCS (Gen. Surg) in 2008 and completed higher surgical training in 2009 and awarded his completion of surgical training certification (CST). Chris was appointed Clinical Senior Lecturer and Honorary Consultant Pancreato-Biliary Surgeon in Liverpool in 2009. Chris was promoted to Reader in 2017 and to Professor of Pancreatic Surgery in 2018. He is the clinical lead and the clinical impact for the Institute of Systems, Molecular & Integrative Biology.
Chris extensively publishes on basic science (SPION technology), clinical research into pancreatic cancer and acute pancreatitis and clinical trials. He is recognised as a trials methodologist, specialising in conduct of surgical trials and as a surgical leader across many committee's and National and International collaborations.
Chris is the clinical lead of the European registry of familial pancreatic cancer and hereditary pancreatitis (EUROPAC). In addition to the registry we use the scientific arm (Europac-PLUS) to drive research that allows us to inform on secondary screening for pancreatic cancer through our surveillance arm (Europac-PRIME).
Prizes or Honours
- FRCSEd (ad hom) (Royal College of Surgeons of Edinburgh, 2024)
- European Pancreatic Club Gold Medal (European Pancreatic Club, 2016)
- Pump Prime Award (RCS England, 2010)
- Society Tankard (North West Society of Surgeons, 2007)
Funded Fellowships
- Pump Priming Award (Pancreatic Soceity GBI, 2006)